Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma

被引:69
作者
Chen, Jingbiao [1 ]
Zhou, Jing [2 ]
Kuang, Sichi [1 ]
Zhang, Yao [1 ]
Xie, Sidong [1 ]
He, Bingjun [1 ]
Deng, Ying [1 ]
Yang, Hao [1 ]
Shan, Qungang [1 ]
Wu, Jun [1 ]
Sirlin, Claude B. [3 ]
Wang, Jin [1 ]
机构
[1] Sun Yat Sen Univ, Dept Radiol, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
[3] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, San Diego, CA 92103 USA
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; Liver Imaging Reporting and Data System; microvascular invasion; MRI; recurrence; PREOPERATIVE PREDICTION;
D O I
10.2214/AJR.19.21168
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. We investigated in Liver Imaging Reporting and Data System category 5 (LR-5) observations whether imaging features, including LI-RADS imaging features, could predict microvascular invasion (MVI) and posthepatectomy recurrence in high-risk adult patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS. We retrospectively identified 149 high-risk patients who underwent 3-T MRI within 1 month before hepatectomy for HCC; 81 of 149 patients with no HCC recurrence were followed for more than 1 year. Tumors with clear surgical margins were confirmed in each hepatectomy specimen. MVI was evaluated histologically by a histopathologist. Tumor recurrence was determined by clinical and imaging follow-up. Two independent radiologists reviewed the prehepatectomy MR images and assessed LI-RADS v2018 imaging features as well as some non-LI-RADS features in all LR-5 observations in consensus. Alpha-fetoprotein level, tumor number, and imaging features were analyzed as potential predictors for MVI and posthepatectomy recurrence using multivariate logistic regression and Cox proportional hazards models. RESULTS. One hundred forty-nine patients with pathologically confirmed HCC were included; 64 of 149 (43.0%) patients had MVI, whereas 48 of 129 (37.2%) patients had tumor recurrence within 3 years after hepatectomy. Mosaic architecture (odds ratio, 3.420; p < 0.001) and nonsmooth tumor margin (odds ratio, 2.554; p = 0.011) were independent predictors of MVI. Multifocal tumors (hazard ratio, 2.101; p = 0.034), absence of fat in mass (hazard ratio, 2.109; p = 0.015), and nonsmooth tumor margin (hazard ratio, 2.415; p = 0.005) were independent predictors of posthepatectomy recurrence. CONCLUSION. In high-risk patients with LR-5 HCC, mosaic architecture and nonsmooth tumor margin independently predicted MVI. Multifocal tumors, absence of fat in mass, and nonsmooth tumor margin independently predicted recurrence.
引用
收藏
页码:821 / 830
页数:10
相关论文
共 36 条
  • [1] American College of Radiology (ACR), 2018, LIV REP DAT SYST LI
  • [2] Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis
    An, Chansik
    Park, Sumi
    Chung, Yong Eun
    Kim, Do-Young
    Kim, Seung-Seob
    Kim, Myeong-Jin
    Choi, Jin-Young
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (03) : 576 - 583
  • [3] Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection
    An, Chansik
    Kim, Dong Wook
    Park, Young-Nyun
    Chung, Yong Eun
    Rhee, Hyungjin
    Kim, Myeong-Jin
    [J]. RADIOLOGY, 2015, 276 (02) : 433 - 443
  • [4] [Anonymous], ORG PROC TRANSPL NET
  • [5] A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma
    Ariizumi, Shun-ichi
    Kitagawa, Koichi
    Kotera, Yoshihito
    Takahashi, Yutaka
    Katagiri, Satoshi
    Kuwatsuru, Ryohei
    Yamamoto, Masakazu
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (04) : 575 - 585
  • [6] Global trends and predictions in hepatocellular carcinoma mortality
    Bertuccio, Paola
    Turati, Federica
    Carioli, Greta
    Rodriguez, Teresa
    La Vecchia, Carlo
    Malvezzi, Matteo
    Negri, Eva
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 302 - 309
  • [7] Hepatocellular carcinoma: clinical frontiers and perspectives
    Bruix, Jordi
    Gores, Gregory J.
    Mazzaferro, Vincenzo
    [J]. GUT, 2014, 63 (05) : 844 - 855
  • [8] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [9] CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects
    Choi, Jin-Young
    Lee, Jeong-Min
    Sirlin, Claude B.
    [J]. RADIOLOGY, 2014, 272 (03) : 634 - 653
  • [10] LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI
    Choi, Sang Hyun
    Lee, Seung Soo
    Park, So Hyun
    Kim, Kang Mo
    Yu, Eunsil
    Park, Yangsoon
    Shin, Yong Moon
    Lee, Moon-Gyu
    [J]. RADIOLOGY, 2019, 290 (02) : 388 - 397